First Time Loading...

Biomerica Inc
NASDAQ:BMRA

Watchlist Manager
Biomerica Inc Logo
Biomerica Inc
NASDAQ:BMRA
Watchlist
Price: 0.571 USD -2.92% Market Closed
Updated: May 8, 2024

Intrinsic Value

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. [ Read More ]

The intrinsic value of one BMRA stock under the Base Case scenario is 0.508 USD. Compared to the current market price of 0.571 USD, Biomerica Inc is Overvalued by 11%.

Key Points:
BMRA Intrinsic Value
Base Case
0.508 USD
Overvaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biomerica Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BMRA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Biomerica Inc

Provide an overview of the primary business activities
of Biomerica Inc.

What unique competitive advantages
does Biomerica Inc hold over its rivals?

What risks and challenges
does Biomerica Inc face in the near future?

Has there been any significant insider trading activity
in Biomerica Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biomerica Inc.

Provide P/S
for Biomerica Inc.

Provide P/E
for Biomerica Inc.

Provide P/OCF
for Biomerica Inc.

Provide P/FCFE
for Biomerica Inc.

Provide P/B
for Biomerica Inc.

Provide EV/S
for Biomerica Inc.

Provide EV/GP
for Biomerica Inc.

Provide EV/EBITDA
for Biomerica Inc.

Provide EV/EBIT
for Biomerica Inc.

Provide EV/OCF
for Biomerica Inc.

Provide EV/FCFF
for Biomerica Inc.

Provide EV/IC
for Biomerica Inc.

Show me price targets
for Biomerica Inc made by professional analysts.

What are the Revenue projections
for Biomerica Inc?

How accurate were the past Revenue estimates
for Biomerica Inc?

What are the Net Income projections
for Biomerica Inc?

How accurate were the past Net Income estimates
for Biomerica Inc?

What are the EPS projections
for Biomerica Inc?

How accurate were the past EPS estimates
for Biomerica Inc?

What are the EBIT projections
for Biomerica Inc?

How accurate were the past EBIT estimates
for Biomerica Inc?

Compare the revenue forecasts
for Biomerica Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biomerica Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biomerica Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biomerica Inc compared to its peers.

Compare the P/E ratios
of Biomerica Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Biomerica Inc with its peers.

Analyze the financial leverage
of Biomerica Inc compared to its main competitors.

Show all profitability ratios
for Biomerica Inc.

Provide ROE
for Biomerica Inc.

Provide ROA
for Biomerica Inc.

Provide ROIC
for Biomerica Inc.

Provide ROCE
for Biomerica Inc.

Provide Gross Margin
for Biomerica Inc.

Provide Operating Margin
for Biomerica Inc.

Provide Net Margin
for Biomerica Inc.

Provide FCF Margin
for Biomerica Inc.

Show all solvency ratios
for Biomerica Inc.

Provide D/E Ratio
for Biomerica Inc.

Provide D/A Ratio
for Biomerica Inc.

Provide Interest Coverage Ratio
for Biomerica Inc.

Provide Altman Z-Score Ratio
for Biomerica Inc.

Provide Quick Ratio
for Biomerica Inc.

Provide Current Ratio
for Biomerica Inc.

Provide Cash Ratio
for Biomerica Inc.

What is the historical Revenue growth
over the last 5 years for Biomerica Inc?

What is the historical Net Income growth
over the last 5 years for Biomerica Inc?

What is the current Free Cash Flow
of Biomerica Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biomerica Inc.

Financials

Balance Sheet Decomposition
Biomerica Inc

Current Assets 8.8m
Cash & Short-Term Investments 5.3m
Receivables 1.1m
Other Current Assets 2.4m
Non-Current Assets 1.5m
Long-Term Investments 165k
PP&E 1m
Intangibles 216k
Other Non-Current Assets 104k
Current Liabilities 2m
Accounts Payable 885k
Accrued Liabilities 1m
Other Current Liabilities 85k
Non-Current Liabilities 543k
Other Non-Current Liabilities 543k
Efficiency

Earnings Waterfall
Biomerica Inc

Revenue
5.4m USD
Cost of Revenue
-4.8m USD
Gross Profit
616k USD
Operating Expenses
-7.3m USD
Operating Income
-6.7m USD
Other Expenses
333k USD
Net Income
-6.3m USD

Free Cash Flow Analysis
Biomerica Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BMRA Profitability Score
Profitability Due Diligence

Biomerica Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

12/100
Profitability
Score

Biomerica Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

BMRA Solvency Score
Solvency Due Diligence

Biomerica Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Biomerica Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BMRA Price Targets Summary
Biomerica Inc

There are no price targets for BMRA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BMRA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BMRA Price
Biomerica Inc

1M 1M
-30%
6M 6M
-39%
1Y 1Y
-57%
3Y 3Y
-86%
5Y 5Y
-75%
10Y 10Y
-38%
Annual Price Range
0.571
52w Low
0.5325
52w High
1.71
Price Metrics
Average Annual Return 16.27%
Standard Deviation of Annual Returns 43.7%
Max Drawdown -97%
Shares Statistics
Market Capitalization 9.6m USD
Shares Outstanding 16 821 600
Percentage of Shares Shorted 0.42%

BMRA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Biomerica Inc Logo
Biomerica Inc

Country

United States of America

Industry

Health Care

Market Cap

9.6m USD

Dividend Yield

0%

Description

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company is headquartered in Irvine, California and currently employs 49 full-time employees. The firm develops, patents, manufactures and markets diagnostic and therapeutic products for the early detection and monitoring of chronic diseases and other medical conditions. The firm's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications, by measuring or detecting the of specific bacteria, hormones, antibodies, antigens, or other substances, in a patient body, stools, or blood, saliva or nasal fluid. The firm is engaged in research and development of disruptive, patented diagnostic guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases.

Contact

CALIFORNIA
Irvine
17571 von Karman Ave
+19496452111.0
http://www.biomerica.com/

IPO

1980-03-17

Employees

49

Officers

Chief Executive Officer
Mr. Zackary S. Irani
Executive Vice-Chairman of the Board & Corporate Secretary
Mr. Allen C. Barbieri
Principal Accounting Officer & CFO
Mr. Gary Lu CPA
Director of Manufacturing & Technical Operations
Ms. Lucy Liu Ph.D.
Chief Commercial Officer
Mr. Robert W. Carlson

See Also

Discover More
What is the Intrinsic Value of one BMRA stock?

The intrinsic value of one BMRA stock under the Base Case scenario is 0.508 USD.

Is BMRA stock undervalued or overvalued?

Compared to the current market price of 0.571 USD, Biomerica Inc is Overvalued by 11%.